Violacein: Properties and production of a versatile bacterial pigment

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Choi, Seong Yeol ^a   Yoon, Kyoung Hye ^b   Lee, Jin Il ^b   Mitchell, Robert J ^a  

^a Ulsan National Institute of Science and Technology   (South Korea)

^b Yonsei University Wonju   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BISINDOLE VIOLACEIN; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NITROGEN; POTASSIUM NITRATE; REACTIVE OXYGEN METABOLITE; TRYPTOPHAN DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; INDOLE DERIVATIVE; PIGMENT; TRYPTOPHAN; VIOLACEIN;

AMINO ACID SYNTHESIS; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; BIOLOGICAL FUNCTIONS; BIOSYNTHESIS; CELL DENSITY; CHROMOBACTERIUM; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HOST RANGE; HOST RESISTANCE; IC50; MICROBULBIFER; NONHUMAN; PHYSICAL CHEMISTRY; PREDATOR; PSEUDOALTEROMONAS; QUORUM SENSING; REGULATORY MECHANISM; RESPONSE SURFACE METHOD; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOMYCES LIVIDANS; SYNTHETIC BIOLOGY; UPREGULATION; CHEMISTRY; DRUG EFFECTS; FERMENTATION; GENETIC ENGINEERING; GENETICS; HUMAN; METABOLISM;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CHROMOBACTERIUM; FERMENTATION; GENETIC ENGINEERING; HUMANS; INDOLES; PIGMENTS, BIOLOGICAL; STAPHYLOCOCCUS AUREUS; TRYPTOPHAN;

EID: 84939545385     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/465056     Document Type: Review

References (61)

1. S. Hakvag, E. Fjvik, G. Klinkenberg et al. , "Violacein-producing Collimonas sp. from the sea surface microlayer of costal waters in Trdelag, Norway, " Marine Drugs, vol. 7, no. 4, pp. 576-588, 2009.
2. H. S. Wang, P. X. Jiang, Y. Lu et al. , "Optimization of culture conditions for violacein production by a new strain of Duganella sp. B2, " Biochemical Engineering Journal, vol. 44, no. 2-3, pp. 119-124, 2009.
3. B. A. Jude, J. Tanner, T. Koko, and E. C. McLaughlin, "Analysis, characterization, and synthesis of violacein from Janthinobacterium isolate extracts, " Abstracts of Papers of the American Chemical Society, vol. 244, 2012.
4. Y. Lu, L. Wang, Y. Xue et al. , "Production of violet pigment by a newly isolated psychrotrophic bacterium from a glacier in Xinjiang, China, " Biochemical Engineering Journal, vol. 43, no. 2, pp. 135-141, 2009.
5. F. Pantanella, F. Berlutti, C. Passariello, S. Sarli, C. Morea, and S. Schippa, "Violacein and biofilm production in Janthinobacterium lividum, " Journal of Applied Microbiology, vol. 102, no. 4, pp. 992-999, 2007.
6. C. Matz, J. S. Webb, P. J. Schupp et al. , "Marine biofilmbacteria evade eukaryotic predation by targeted chemical defense, " PLoS ONE, vol. 3, no. 7, Article ID e2744, 2008.
7. L. H. Yang, H. Xiong, O. O. Lee, S.-H. Qi, and P.-Y. Qian, "Effect of agitation on violacein production in Pseudoalteromonas luteoviolacea isolated from a marine sponge, " Letters in Applied Microbiology, vol. 44, no. 6, pp. 625-630, 2007.
8. X. Zhang and K. Enomoto, "Characterization of a gene cluster and its putative promoter region for violacein biosynthesis in Pseudoalteromonas sp. 520P1, " Applied Microbiology and Biotechnology, vol. 90, no. 6, pp. 1963-1971, 2011.
9. S. A. Mccarthy, R. M. Johnson, D. kakimoto, and T. sakata, "Effects of various agents on the pigment (violacein) and antibiotic production of Alteromonas luteoviolacea, " Bulletin of the Japanese Society of Scientific Fisheries, vol. 51, no. 7, pp. 1115-1121, 1985.
10. S. Aranda, M. Montes-Borrego, and B. B. Landa, "Purplepigmented violacein-producing Duganella spp. inhabit the rhizosphere of wild and cultivated olives in Southern Spain, " Microbial Ecology, vol. 62, no. 2, pp. 446-459, 2011.
11. J. A. Avgustin, D. Z. Bertok, R. Kostanjsek, and G. Avgustin, "Isolation and characterization of a novel violacein-like pigment producing psychrotrophic bacterial species Janthinobacterium svalbardensis sp. nov, " Antonie van Leeuwenhoek, International Journal ofGeneraland MolecularMicrobiology, vol. 103, no. 4, pp. 763-769, 2013.
12. S. J. Kim, S. C. Shin, S. G. Hong et al. , "Genome sequence of Janthinobacterium sp. strain PAMC 25724, isolated from alpine glacier cryoconite, " Journal of Bacteriology, vol. 194, no. 8, pp. 2096-2096, 2012.
13. T. Hoshino, "Violacein and related tryptophanmetabolites produced by Chromobacterium violaceum: biosynthetic mechanism and pathway for construction of violacein core, " Applied Microbiology and Biotechnology, vol. 91, no. 6, pp. 1463-1475, 2011.
14. M. O. Moss, C. Ryall, and N. A. Logan, "The classification and characterization of chromobacteria from a lowland river, " Journal of General Microbiology, vol. 105, no. 1, pp. 11-21, 1978.
15. N. D. Durn and C. F. M. Menck, "Chromobacteriumviolaceum: a review of pharmacologicaland industiral perspectives, " Critical Reviews in Microbiology, vol. 27, no. 3, pp. 201-222, 2001.
16. K. H. McClean, M. K. Winson, L. Fish et al. , "Quorum sensing and Chromobacterium violaceum: exploitation of violacein productioNandinhibition for the detection of N-acylhomoserine lactones, " Microbiology, vol. 143, no. 12, pp. 3703-3711, 1997.
17. S. A. Burt, V. T. A. Ojo-Fakunle, J. Woertman, and E. J. A. Veldhuizen, "The natural antimicrobial carvacrol inhibits quorumsensing in Chromobacteriumviolaceum and reduces bacterial biofilm formation at sub-lethal concentrations, " PLoS ONE, vol. 9, no. 4, Article IDe93414, 2014.
18. P. S. Rajesh and V. Ravishankar Rai, "Quorum quenching activity in cell-free lysate of endophytic bacteria isolated from Pterocarpus santalinus Linn. , and its effect on quorum sensing regulated biofilm in Pseudomonas aeruginosa PAO1, " Microbiological Research, vol. 169, no. 7-8, pp. 561-569, 2014.
19. J. C. Taganna, J. P. Quanico, R. M. G. Perono, E. C. Amor, and W. L. Rivera, "Tannin-rich fraction from Terminalia catappa inhibits quorum sensing (QS) in Chromobacterium violaceum and the QS-controlled biofilm maturation and LasA staphylolytic activity in Pseudomonas aeruginosa, " Journal of Ethnopharmacology, vol. 134, no. 3, pp. 865-871, 2011.
20. M. Durn, A. Faljoni-Alario, and N. Durn, "Chromobacterium violaceuMandits important metabolites-review, " Folia Microbiologica, vol. 55, no. 6, pp. 535-547, 2010.
21. W. A. Ahmad, N. Z. Yusof, N. Nordin, Z. A. Zakaria, and M. F. Rezali, "Production and characterization of violacein by locally isolated Chromobacterium violaceum grown in agricultural wastes, " Applied Biochemistry and Biotechnology, vol. 167, no. 5, pp. 1220-1234, 2012.
22. W. J. Li, Y. Q. Zhang, D. J. Park et al. , "Duganella violaceinigra sp. nov. , a novelmesophilic bacteriumisolated from forest soil, " International Journal of Systematic and Evolutionary Microbiology, vol. 54, part 5, pp. 1811-1814, 2004.
23. S. Yada, Y. Wang, Y. Zou et al. , "Isolation and characterization of two groups of novel marine bacteria producing violacein, " Marine Biotechnology, vol. 10, no. 2, pp. 128-132, 2008.
24. R. M. Brucker, R. N. Harris, C. R. Schwantes et al. , "Amphibian chemical defense: antifungal metabolites of the microsymbiont Janthinobacterium lividum on the salam and er Plethodon cinereus, " Journal of Chemical Ecology, vol. 34, no. 11, pp. 1422-1429, 2008.
25. L. L. Leon, C. C. Miranda, A. O. de Souza, and N. Durn, "Antileishmanial activity of the violacein extracted from Chromobacterium violaceum, " Journal of Antimicrobial Chemotherapy, vol. 48, no. 3, pp. 449-450, 2001.
26. S. C. P. Lopes, Y. C. Blanco, G. Z. Justo et al. , "Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo, " Antimicrobial Agents and Chemotherapy, vol. 53, no. 5, pp. 2149-2152, 2009.
27. C. Hornung, A. Poehlein, F. S. Haack et al. , "The Janthinobacterium sp. HH01 Genome Encodes a Homologue of the V. cholerae CqsA and L. pneumophila LqsA Autoinducer Synthases, " PLoS ONE, vol. 8, no. 2, Article ID e55045, 2013.
28. P. da SilvaMelo, S. S. Maria, B. de Campos Vidal, M. Haun, and N. Durn, "Violacein cytotoxicity and induction of apoptosis in V79 cells, " In Vitro Cellular and Developmental Biology-Animal, vol. 36, no. 8, pp. 539-543, 2000.
29. C. R. Andrighetti-Frhner, R. V. Antonio, T. B. Creczynski-Pasa, C. R. M. Barardi, and C. M. O. Simoes, "Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacteriumviolaceum, " Memorias do Instituto Oswaldo Cruz, vol. 98, no. 6, pp. 843-848, 2003.
30. V. S. Saraiva, J.-C. Marshall, J. Cools-Lartigue, and M. N. Burnier Jr. , "Cytotoxic effects of violacein in human uvealmelanoma cell lines, " Melanoma Research, vol. 14, no. 5, pp. 421-424, 2004.
31. D. D. de Carvalho, F. T. M. Costa, N. Duran, and M. Haun, "Cytotoxic activity of violacein in human colon cancer cells, " Toxicology in Vitro, vol. 20, no. 8, pp. 1514-1521, 2006.
32. L. L. Kodach, C. L. Bos, N. Durn, M. P. Peppelenbosch, C. V. Ferreira, and J. C. H. Hardwick, "Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells, " Carcinogenesis, vol. 27, no. 3, pp. 508-516, 2006.
33. K. C. S. Queiroz, R. Milani, R. R. Ruela-de-Sousa et al. , "Violacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapse, " PLoS ONE, vol. 7, no. 10, Article IDe45362, 2012.
34. C. V. Ferreira, C. L. Bos, H. H. Versteeg, G. Z. Justo, N. Durn, and M. P. Peppelenbosch, "Molecular mechanism of violaceinmediated human leukemia cell death, " Blood, vol. 104, no. 5, pp. 1459-1464, 2004.
35. N. Bromberg, J. L. Dreyfuss, C. V. Regatieri et al. , "Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor, " Chemico-Biological Interactions, vol. 186, no. 1, pp. 43-52, 2010.
36. H. C. Lichstein and V. F. van de Sand , "Violacein, an antibiotic pigment produced by Chromobacterium violaceum, " Journal of Infectious Diseases, vol. 76, no. 1, pp. 47-51, 1945.
37. Y. Nakamura, T. Sawada, Y. Morita, and E. Tamiya, "Isolation of a psychrotrophic bacterium from the organic residue of a water tank keeping rainbow trout and antibacterial effect of violet pigment produced from the strain, " Biochemical Engineering Journal, vol. 12, no. 1, pp. 79-86, 2002.
38. Y. Nakamura, C. Asada, and T. Sawada, "Production of antibacterial violet pigment by psychrotropic bacterium RT102 strain, " Biotechnology and Bioprocess Engineering, vol. 8, no. 1, pp. 37-40, 2003.
39. N. G. Vynne, M. Mansson, and L. Gram, "Gene sequence based clustering assists in dereplication of Pseudoalteromonas luteoviolacea strains with identical inhibitory activity and antibiotic production, " Marine Drugs, vol. 10, no. 8, pp. 1729-1740, 2012.
40. S. Subramaniam, V. Ravi, and A. Sivasubramanian, "Synergistic antimicrobial profiling of violacein with commercial antibiotics against pathogenic micro-organisms, " Pharmaceutical Biology, vol. 52, no. 1, pp. 86-90, 2014.
41. P. D. Melo, S. S. Maria, B. D. Vidal, M. Haun, and N. Duran, "Violacein cytotoxicity and induction of apoptosis in V79 cells, " In Vitro Cellular and Developmental Biology-Animal, vol. 36, no. 8, pp. 539-543, 2000.
42. S. Brenner, "The genetics of Caenorhabditis elegans, " Genetics, vol. 77, no. 1, pp. 71-94, 1974.
43. A. Fire, S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver, and C. C. Mello, "Potent and specific genetic interference by doublestr and ed RNA in caenorhabditis elegans, " Nature, vol. 391, no. 6669, pp. 806-811, 1998.
44. R. C. Lee, R. L. Feinbaum, and V. Ambros, "The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, " Cell, vol. 75, no. 5, pp. 843-854, 1993.
45. M. O. Hengartner and H. R. Horvitz, "Programmed cell death in Caenorhabditis elegans, " Current Opinion in Genetics and Development, vol. 4, no. 4, pp. 581-586, 1994.
46. L. R. Swem, D. L. Swem, C. T. OLoughlin et al. , "A quorumsensing antagonist targets bothmembrane-bound and cytoplasmic receptors and controls bacterial pathogenicity, " Molecular Cell, vol. 35, no. 2, pp. 143-153, 2009.
47. R. N. Harris, R. M. Brucker, J. B. Walke et al. , "Skin microbes on frogs prevent morbidity and mortality caused by a lethal skin fungus, " The ISME Journal, vol. 3, no. 7, pp. 818-824, 2009.
48. S. Subramaniam, V. Ravi, and A. Sivasubramanian, "Synergistic antimicrobial profiling of violacein with commercial antibiotics against pathogenic micro-organisms, " Pharmaceutical Biology, vol. 52, no. 1, pp. 86-90, 2014.
49. A. S. Mendes, J. E. de Carvalho, M. C. T. Duarte, N. Durn, and R. E. Bruns, "Factorial design and response surface optimization of crude violacein for Chromobacteriumviolaceumproduction, " Biotechnology Letters, vol. 23, no. 23, pp. 1963-1969, 2001.
50. R. Riveros, M. Haun, and N. Durn, "Effect of growth conditions on production of violacein by Chromobacterium violaceum (BB-78 strain), " Brazilian Journal of Medicaland Biological Research, vol. 22, no. 5, pp. 569-577, 1989.
51. A. L. Rodrigues, N. Trachtmann, J. Becker et al. , "Systems metabolic engineering of Escherichia coli for production of the antitumor drugs violacein and deoxyviolacein, "Metabolic Engineering, vol. 20, pp. 29-41, 2013.
52. D. Rettori and N. Durn, "Production, extraction and purification of violacein: an antibiotic pigment produced by Chromobacterium violaceum, "World Journal of Microbiology and Biotechnology, vol. 14, no. 5, pp. 685-688, 1998.
53. P. R. August, T. H. Grossman, C. Minor et al. , "Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum, " Journal of Molecular Microbiology and Biotechnology, vol. 2, no. 4, pp. 513-519, 2000.
54. D. S. Sarovich and J. M. Pemberton, "pPSX: a novel vector for the cloning and heterologous expression of antitumor antibiotic gene clusters, " Plasmid, vol. 57, no. 3, pp. 306-313, 2007.
55. A. Ahmetagic and J. M. Pemberton, "Stable high level expression of the violacein indolocarbazole anti-tumour gene cluster and the Streptomyces lividans amyAgene in E. coli K12, " Plasmid, vol. 63, no. 2, pp. 79-85, 2010.
56. P.-X. Jiang, H.-S. Wang, C. Zhang, K. Lou, and X.-H. Xing, "Reconstruction of the violacein biosynthetic pathway from Duganella sp. B2 in different heterologous hosts, "AppliedMicrobiology and Biotechnology, vol. 86, no. 4, pp. 1077-1088, 2010.
57. A. L. Rodrigues, Y. Gcke, C. Bolten, N. L. Brock, J. S. Dickschat, and C. Wittmann, "Microbial production of the drugs violacein and deoxyviolacein: analytical development and strain comparison, " Biotechnology Letters, vol. 34, no. 4, pp. 717-720, 2012.
58. P.-X. Jiang, H.-S. Wang, S. Xiao et al. , "Pathway redesign for deoxyviolacein biosynthesis in Citrobacter freundii and characterization of this pigment, " AppliedMicrobiology and Biotechnology, vol. 94, no. 6, pp. 1521-1532, 2012.
59. C. Snchez, A. F. Brana, C. Mndez, and J. A. Salas, "Reevaluation of the violacein biosynthetic pathway and its relationship to indolocarbazole biosynthesis, " ChemBioChem, vol. 7, no. 8, pp. 1231-1240, 2006.
60. T. Hoshino and N. Ogasawara, "Biosynthesis of violacein: evidence for the intermediacy of 5-hydroxy-L-tryptophan and the structure of a new pigment, oxyviolacein, produced by the metabolism of 5-hydroxytryptophan, " Agriculturaland Biological Chemistry, vol. 54, no. 9, pp. 2339-2346, 1990.
61. H. S. Wang, F. Z. Wang, X. F. Zhu et al. , "Biosynthesis and characterization of violacein, deoxyviolacein and oxyviolacein in heterologous host, and their antimicrobial activities, " Biochemical Engineering Journal, vol. 67, pp. 148-155, 2012.